Transcend Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
80 5th Ave Fl 18, New York, New York, 10...Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Transcend Therapeutics
Transcend Therapeutics is focused on developing rapid-acting treatments for neuropsychiatric diseases, particularly PTSD. Their lead product, TSND-201 (methylone), aims to provide effective solutions for patients who have not responded to traditional psychiatric medications. The company is dedicated to improving mental health outcomes and strives for a world free from neuropsychiatric disorders. They actively engage in research and clinical studies to advance their innovative therapies.Explore more
Transcend Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Transcend Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Transcend Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Transcend Therapeutics had a recent Job posting/layoffs
Check out if Transcend Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Transcend Therapeutics
Check if Transcend Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Transcend Therapeutics has new funding data
Earning: See what the market has to say on Transcend Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Transcend Therapeutics launches new products
Recommended Actions
Find VP level buyers at Transcend Therapeutics
Find more new buyers
Compare Similar Companies to Transcend Therapeutics
Compare insights from companies similar to Transcend Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Transcend Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Transcend Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Transcend Therapeutics.
Transcend Therapeutics financials insights
Gather financial insights about Transcend Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$40M
Transcend Therapeutics Tech Stack
A closer look at the technologies used by Transcend Therapeutics
Most Recent Scoops
Person-Based
Project
Laboratory Operations, Medical Research, Clinical Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Hiring Plans
Transcend Therapeutics has more open roles in Medical & Health than it has had at any time in the past 12 months with an increased focus that include Psychiatry, Clinical Trials, Drug Development, Clinical System Operations, Clinical System Operations, and Psychiatry, and experience with Life Sciences.
Hiring Plans
Open Position
Transcend Therapeutics News & Media
Transcend Therapeutics Announces Completion of Acquisition by Otsuka Pharmaceutical
NEW YORK, June 12, 2026 /PRNewswire/ -- Transcend Therapeutics today announced the completion of its acquisition by Otsuka America Inc., a subsidiary of Otsuka Pharmaceutical Co., Ltd. (Otsuka), marking a significant milestone in Transcend's mission to develop rapid-acting treatments for...Transcend Therapeutics Receives Breakthrough Therapy Designation for TSND-201 (methylone) for the Treatment of PTSD
Designation offers potential for expedited development of TSND-201 for the treatment of PTSD Company planning to initiate Phase 3 program NEW YORK, July 10, 2025 /PRNewswire/ -- Transcend Therapeutics, a clinical-stage biotechnology company that develops medicines to treat...Transcend Therapeutics Announces Primary Endpoint Met in IMPACT-1 Phase 2 Study of TSND-201 in PTSD
Primary endpoint met, with TSND-201 demonstrating statistically significant placebo-adjusted CAPS-5 improvement of -9.64 points on Day 64 (p = 0.011) TSND-201 demonstrated rapid improvements, with a statistically significant placebo-adjusted CAPS-5 improvement of -8.00 points on Day 10 (p...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Transcend Therapeutics
Sign Up For FreeTo access detailed company insights
Transcend Therapeutics is focused on developing rapid-acting treatments for neuropsychiatric diseases, particularly PTSD. Their lead product, TSND-201 (methylone), aims to provide effective solutions for patients who have not responded to traditional psychiatric medications. The company is dedicated to improving mental health outcomes and strives f... Read More
